Currently, novel mouse models of
melanoma are being generated that recapitulate the histopathology and molecular pathogenesis observed in human disease. Impaired cell-cycle control, which is a hallmark of both familial and sporadic
melanoma, promotes slowly growing
carcinogen-induced
melanomas in the skin of mice carrying a mutated
cyclin-dependent kinase 4 (CDK4(R24C)). Deregulated
receptor tyrosine kinase signaling, which is another important feature of human
melanoma, leads to spontaneous development of metastatic
melanoma after a long latency period in mice overexpressing
hepatocyte growth factor/
scatter factor (HGF/SF mice). Here we report that treatment with 7,12-dimethylbenz[a]
anthracene and 12-O-tetradecanoylphorbol-13-acetate induced metastatic
melanomas in all HGF/SF mice on the C57BL/6 background, which histologically resemble human
melanoma. Importantly, mutant CDK4 dramatically increased the number and the growth kinetics of
carcinogen-induced primary
melanomas in the skin and promoted the growth of spontaneous
metastases in lymph nodes and lungs in all HGF/SF mice within the first 3 months of life. Apart from very few skin
papillomas, we did not observe
tumors of other histology in
carcinogen-treated HGF/SF x CDK4(R24C) mice. This new experimental mouse model can now be exploited to study further the biology of
melanoma and evaluate new treatment modalities.